Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, 00168, Italy
Location status: Recruiting
NCT Number: NCT07588971
Epilepsy is one of the most common neurological diseases in Italy, affecting about 500,000 people. Pediatric age represents one of the most affected groups with a consequent significant impact on the quality of life of the families involved.
The study aims to monitor the cognitive functions of patients followed at our center in order to determine the main types of pathways and highlight their determinants. The ultimate goal is to define what are the main clinical and instrumental predictors of cognitive function and its variation over time.
Interested in participating?
Request InfoUp to 18 year
All sexes
Observational
Rome, 00168, Italy
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 months after entry visit
Evaluate prescholar global development and scholar cognitive level with Griffiths or Weschler scales where applicable according to age.
Time frame: 24 months after entry visit
Evaluate the reduction in seizures (percentage)
Time frame: 24 months after entry visit
Evaluate the Impact of the Epilepsy on the quality of life
Time frame: 24 months after entry visit
Evaluate the global clinical impression to have a measure of epilepsy severity and the burden of antiseizure medication on daily life.
Contact information is provided by the study sponsor or research team.
Domenica Immacolata Battaglia, MD
CONTACT
Michela Quintiliani, MD
CONTACT
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
Natural History and Prognosis of Pediatric Epilepsies With Different Etiology: Long-term Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02107989
Brain Diseases, Central Nervous System Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06660394
Brain Diseases, Central Nervous System Diseases
Little Rock, Arkansas, United States
View Trial DetailsNCT02531880
Brain Diseases, Central Nervous System Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT01273129
Brain Diseases, Central Nervous System Diseases
Bethesda, Maryland, United States
View Trial Details